360 related articles for article (PubMed ID: 31069800)
1. How is alpha-synuclein cleared from the cell?
Stefanis L; Emmanouilidou E; Pantazopoulou M; Kirik D; Vekrellis K; Tofaris GK
J Neurochem; 2019 Sep; 150(5):577-590. PubMed ID: 31069800
[TBL] [Abstract][Full Text] [Related]
2. Potential Modes of Intercellular α-Synuclein Transmission.
Valdinocci D; Radford RA; Siow SM; Chung RS; Pountney DL
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241427
[TBL] [Abstract][Full Text] [Related]
3. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation.
George S; Brundin P
J Parkinsons Dis; 2015; 5(3):413-24. PubMed ID: 26406122
[TBL] [Abstract][Full Text] [Related]
5. Truncation or proteolysis of α-synuclein in Parkinsonism.
Suthar SK; Lee SY
Ageing Res Rev; 2023 Sep; 90():101978. PubMed ID: 37286088
[TBL] [Abstract][Full Text] [Related]
6. Molecular events underlying the cell-to-cell transmission of α-synuclein.
Choi YR; Park SJ; Park SM
FEBS J; 2021 Dec; 288(23):6593-6602. PubMed ID: 33332736
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxic or neuroprotective: Post-translational modifications of α-synuclein at the cross-roads of functions.
Gadhavi J; Patel M; Bhatia D; Gupta S
Biochimie; 2022 Jan; 192():38-50. PubMed ID: 34582997
[TBL] [Abstract][Full Text] [Related]
8. p62/SQSTM1-dependent autophagy of Lewy body-like α-synuclein inclusions.
Watanabe Y; Tatebe H; Taguchi K; Endo Y; Tokuda T; Mizuno T; Nakagawa M; Tanaka M
PLoS One; 2012; 7(12):e52868. PubMed ID: 23300799
[TBL] [Abstract][Full Text] [Related]
9. α-Synuclein ubiquitination and novel therapeutic targets for Parkinson's disease.
Rott R; Szargel R; Shani V; Bisharat S; Engelender S
CNS Neurol Disord Drug Targets; 2014; 13(4):630-7. PubMed ID: 24168368
[TBL] [Abstract][Full Text] [Related]
10. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
11. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
12. Role of Ubiquitin-Proteasome and Autophagy-Lysosome Pathways in α-Synuclein Aggregate Clearance.
Sahoo S; Padhy AA; Kumari V; Mishra P
Mol Neurobiol; 2022 Sep; 59(9):5379-5407. PubMed ID: 35699874
[TBL] [Abstract][Full Text] [Related]
13. Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.
Oueslati A; Fournier M; Lashuel HA
Prog Brain Res; 2010; 183():115-45. PubMed ID: 20696318
[TBL] [Abstract][Full Text] [Related]
14. Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease.
Lee SJ
J Mol Neurosci; 2008; 34(1):17-22. PubMed ID: 18157654
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
Blanz J; Saftig P
J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
[TBL] [Abstract][Full Text] [Related]
16. Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics?
Mavroeidi P; Vetsi M; Dionysopoulou D; Xilouri M
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883513
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.
Chistiakov DA; Chistiakov AA
Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175
[TBL] [Abstract][Full Text] [Related]
18. Propagation of pathological α-synuclein in marmoset brain.
Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
[TBL] [Abstract][Full Text] [Related]
19. Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome.
Petroi D; Popova B; Taheri-Talesh N; Irniger S; Shahpasandzadeh H; Zweckstetter M; Outeiro TF; Braus GH
J Biol Chem; 2012 Aug; 287(33):27567-79. PubMed ID: 22722939
[TBL] [Abstract][Full Text] [Related]
20. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
